FilingReader Intelligence
Walvax Bio signs strategic partnership with state-owned capital firm
July 23, 2025 at 09:31 AM UTC•By FilingReader AI
Walvax Biotechnology signed a strategic cooperation framework agreement with Yuxi State-owned Capital Operation on July 22, 2025, focusing on vaccine and biopharmaceutical sectors.
The agreement aims to optimize Walvax's equity structure, strengthen capital, and accelerate industry upgrades, though specific terms and financial commitments are yet to be finalized.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Walvax Biotechnology publishes news
Free account required • Unsubscribe anytime